Studies on Pr3+–Yb3+ codoped ZBLA as rare earth down convertor glasses for solar cells encapsulation

The non-absorption of photons with energies below the bandgap (Eg) and the thermalization of photons with energies higher than Eg are the dominant loss processes of single-junction solar cells. Rare earth doped glasses give the opportunity to convert the incident photons wavelength and hence to increase or decrease their energies. The conversion of photons energies by “up or down conversion” leads to the possibility to increase the efficiencies of all classes of single-junction solar cells. Depending on the nature of doping materials, two low energy photons can be converted into one high-energy photon (up-conversion), or one high energy photon, can be converted into two low energy photons (down-conversion). In this paper, Pr3+–Yb3+ down-conversion co-doped ZBLA glasses were tested as encapsulation materials for silicon solar cells. The J–V characterizations were done under solar simulator irradiation. The influence of Yb3+ concentration on the solar cells performances was investigated, showing that an optimum value between 0.5 and 2 mol% conducts to an increase of the device efficiency comparing to mono-doped ZBLA material

Site selection spectroscopy in Eu3+-doped lanthanum fluorozirconate glass and glass-ceramic

The optical properties of Eu3+-doped glass and transparent glass-ceramic with composition (in mol%) 70.2ZrF4–23.4LaF3–0.6AlF3–5.8GaF3 were investigated by site selective spectroscopy in order to study the effect of ceramization on the symmetry of Eu3 + sites. The glass-ceramic obtained after thermal treatment of the glass ZLAG contains a unique crystalline phase of unknown structure. The analysis and comparison of FLN spectra in these materials are presented and different classes of sites are discussed. We found the presence of two main site distributions for Eu3+ ions of equivalent symmetry (C2v or lower) in the glass and two sites of different symmetry (C2v or lower and C4v or lower) in tthe glass-ceramic (GC). The estimated average crystal field strength for glass and GC decreases with the 5D0 → 7F0 energy. The results suggest that the two kinds of sites identified in the glass correspond to Eu3+ ions in and out of the former network. Decay-time measurements of 5D0 level of Eu3 + evidenced energy transfer between high and low energy sites and showed an increase of lifetime from the glass to the glass-ceramic

International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg−1 per day starting dose of oral corticosteroids to treat bullous pemphigoid

BackgroundEuropean guidelines propose a 0 center dot 5 mg kg(-1) per day dose of oral prednisone as initial treatment for bullous pemphigoid (BP). We assessed the safety and efficacy of this regimen depending on BP extent and general condition of the patients.MethodsIn a prospective international study, we consecutively included all patients diagnosed with BP. Patients received a 0 center dot 5 mg kg(-1) per day dose of prednisone, which was then gradually tapered 15 days after disease control, with the aim of stopping prednisone or maintaining minimal treatment (0 center dot 1 mg kg(-1) per day) within 6 months after the start of treatment. The two coprimary endpoints were control of disease activity at day 21 and 1-year overall survival. Disease severity was assessed according to the Bullous Pemphigoid Disease Area Index (BPDAI) score.ResultsIn total, 198 patients were included between 2015 and 2017. The final analysis comprised 190 patients with a mean age of 80 center dot 9 (SD 9 center dot 1) years. Control of disease activity was achieved at day 21 in 119 patients [62 center dot 6%, 95% confidence interval (CI) 55 center dot 3-69.5]; 18 of 24 patients (75%, 95% CI 53 center dot 3-90 center dot 2), 75 of 110 patients (68 center dot 8%, 95% CI 59 center dot 2-77 center dot 3) and 26 of 56 patients (46.4%, 95% CI 33 center dot 0-60 center dot 3) had mild, moderate and severe BP, respectively (P = 0 center dot 0218). A total of 30 patients died during the study. The overall Kaplan-Meier 1-year survival was 82 center dot 6% (95% CI 76 center dot 3-87 center dot 4) corresponding to 90 center dot 9%, 83 center dot 0% and 80 center dot 0% rates in patients with mild, moderate and severe BP, respectively (P = 0 center dot 5). Thresholds of 49 points for BPDAI score and 70 points for Karnofsky score yielded maximal Youden index values with respect to disease control at day 21 and 1-year survival, respectively.ConclusionsA 0 center dot 5 mg kg(-1) per day dose of prednisone is a valuable therapeutic option in patients with mild or moderate BP whose general condition allows them to be autonomous.</p

Structure and density of Fe-C liquid alloys under high pressure

International audienceThe density and structure of liquid Fe-C alloys have been measured up to 58 GPa and 3,200 K by in situ X-ray diffraction using a Paris-Edinburgh press and laser-heated diamond anvil cell. Study of the pressure evolution of the local structure inferred by X-ray diffraction measurements is important to understand the compression mechanism of the liquid. Obtained data show that the degree of compression is greater for the first coordination sphere than the second and third coordination spheres. The extrapolation of the measured density suggests that carbon cannot be the only light element alloyed to iron in the Earth's core, as 8-16 at % C (1.8-3.7 wt % C) would be necessary to explain the density deficit of the outer core relative to pure Fe. This concentration is too high to account for outer core velocity. The presence of other light elements (e.g., O, Si, S, and H) is thus required

Asbestos-related pleural and lung fibrosis in patients with retroperitoneal fibrosis

<p>Abstract</p> <p>Background</p> <p>Retroperitoneal fibrosis (RPF) is a rare fibroinflammatory disease that leads to hydronephrosis and renal failure. In a case-control study, we have recently shown that asbestos exposure was the most important risk factor for RPF in the Finnish population. The aim of this study was to evaluate the relation of asbestos exposure to radiologically confirmed lung and pleural fibrosis among patients with RPF.</p> <p>Methods</p> <p>Chest high-resolution computed tomography (HRCT) was performed on 16 unexposed and 22 asbestos-exposed RPF patients and 18 asbestos-exposed controls. Parietal pleural plaques (PPP), diffuse pleural thickening (DPT) and parenchymal fibrosis were scored separately.</p> <p>Results</p> <p>Most of the asbestos-exposed RPF patients and half of the asbestos-exposed controls had bilateral PPP, but only a few had lung fibrosis. Minor bilateral plaques were detected in two of the unexposed RPF patients, and none had lung fibrosis. DPT was most frequent and thickest in the asbestos-exposed RPF-patients. In three asbestos-exposed patients with RPF we observed exceptionally large pleural masses that were located anteriorly in the pleural space and continued into the anterior mediastinum.</p> <p>Asbestos exposure was associated with DPT in comparisons between RPF patients and controls (case-control analysis) as well as among RPF patients (case-case analysis).</p> <p>Conclusion</p> <p>The most distinctive feature of the asbestos-exposed RPF patients was a thick DPT. An asbestos-related pleural finding was common in the asbestos-exposed RPF patients, but only a few of these patients had parenchymal lung fibrosis. RPF without asbestos exposure was not associated with pleural or lung fibrosis. The findings suggest a shared etiology for RPF and pleural fibrosis and furthermore possibly a similar pathogenetic mechanisms.</p

Hyper-IgG4 disease: report and characterisation of a new disease

BACKGROUND: We highlight a chronic inflammatory disease we call 'hyper-IgG4 disease', which has many synonyms depending on the organ involved, the country of origin and the year of the report. It is characterized histologically by a lymphoplasmacytic inflammation with IgG4-positive cells and exuberant fibrosis, which leaves dense fibrosis on resolution. A typical example is idiopathic retroperitoneal fibrosis, but the initial report in 2001 was of sclerosing pancreatitis. METHODS: We report an index case with fever and severe systemic disease. We have also reviewed the histology of 11 further patients with idiopathic retroperitoneal fibrosis for evidence of IgG4-expressing plasma cells, and examined a wide range of other inflammatory conditions and fibrotic diseases as organ-specific controls. We have reviewed the published literature for disease associations with idiopathic, systemic fibrosing conditions and the synonyms: pseudotumour, myofibroblastic tumour, plasma cell granuloma, systemic fibrosis, xanthofibrogranulomatosis, and multifocal fibrosclerosis. RESULTS: Histology from all 12 patients showed, to varying degrees, fibrosis, intense inflammatory cell infiltration with lymphocytes, plasma cells, scattered neutrophils, and sometimes eosinophilic aggregates, with venulitis and obliterative arteritis. The majority of lymphocytes were T cells that expressed CD8 and CD4, with scattered B-cell-rich small lymphoid follicles. In all cases, there was a significant increase in IgG4-positive plasma cells compared with controls. In two cases, biopsies before and after steroid treatment were available, and only scattered plasma cells were seen after treatment, none of them expressing IgG4. Review of the literature shows that although pathology commonly appears confined to one organ, patients can have systemic symptoms and fever. In the active period, there is an acute phase response with a high serum concentration of IgG, and during this phase, there is a rapid clinical response to glucocorticoid steroid treatment. CONCLUSION: We believe that hyper-IgG4 disease is an important condition to recognise, as the diagnosis can be readily verified and the outcome with treatment is very good